Mark Vergnano - 02 Dec 2021 Form 4 Insider Report for Chemours Co (CC)

Role: Director
Signature: /s/ Pauletta Brown, Attorney-in-Fact
Issuer symbol: CC
Transactions as of: 02 Dec 2021
Net transactions value: -$1,146,633
Form type: 4
Filing time: 03 Dec 2021, 17:21:40 UTC
Previous filing: 30 Aug 2021
Next filing: 15 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CC	Common Stock	Options Exercise	$1,844,410	+99,968	+72%	$18.45	238,880	02 Dec 2021	Direct	F1, F2
transaction	CC	Common Stock	Sale	$2,991,043	-99,968	-42%	$29.92	138,912	02 Dec 2021	Direct	F1, F2, F3
holding	CC	Common Stock						507,714	02 Dec 2021	By GRAT
holding	CC	Common Stock						187,089	02 Dec 2021	By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CC	Stock Option (Right to Buy)	Options Exercise	$0	-99,968	-100%	$0.000000^*	0	02 Dec 2021	Common Stock	99,968	$18.45	Direct	F1, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2021.
F2	Includes directly owned shares, restricted stock units, and dividend equivalent units.
F3	Shares were sold in multiple transactions at prices ranging from $29.58 to $30.16.
F4	Option award was granted on February 4, 2015 with vesting in three equal annual installments beginning February 4, 2016.